EB05
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EB05, covering 2024-11-14 to 2024-11-14. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19 [Phase 2, Phase 3]